Physical activity and clustered cardiovascular disease risk factors in young children : a cross-sectional study (the IDEFICS study) by Jiménez-Pávon, David et al.
Jiménez-Pavón et al. BMC Medicine 2013, 11:172
http://www.biomedcentral.com/1741-7015/11/172RESEARCH ARTICLE Open AccessPhysical activity and clustered cardiovascular
disease risk factors in young children:
a cross-sectional study (the IDEFICS study)
David Jiménez-Pavón1,2*, Kenn Konstabel3, Patrick Bergman4, Wolfgang Ahrens5, Hermann Pohlabeln5,
Charalampos Hadjigeorgiou6, Alfonso Siani7, Licia Iacoviello8, Dénes Molnár9, Stefaan De Henauw10,
Yannis Pitsiladis11, Luis A Moreno1 and On behalf of the IDEFICS consortiumAbstract
Background: The relevance of physical activity (PA) for combating cardiovascular disease (CVD) risk in children has
been highlighted, but to date there has been no large-scale study analyzing that association in children aged ≤9
years of age. This study sought to evaluate the associations between objectively-measured PA and clustered CVD
risk factors in a large sample of European children, and to provide evidence for gender-specific recommendations
of PA.
Methods: Cross-sectional data from a longitudinal study in 16,224 children aged 2 to 9 were collected. Of these,
3,120 (1,016 between 2 to 6 years, 2,104 between 6 to 9 years) had sufficient data for inclusion in the current
analyses. Two different age-specific and gender-specific clustered CVD risk scores associated with PA were
determined. First, a CVD risk factor (CRF) continuous score was computed using the following variables: systolic
blood pressure (SBP), total triglycerides (TG), total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-c) ratio,
homeostasis model assessment of insulin resistance (HOMA-IR), and sum of two skinfolds (score CRFs). Secondly,
another CVD risk score was obtained for older children containing the score CRFs + the cardiorespiratory fitness
variable (termed score CRFs + fit). Data used in the current analysis were derived from the IDEFICS (‘Identification
and prevention of Dietary- and lifestyle-induced health EFfects In Children and infantS’) study.
Results: In boys <6 years, the odds ratios (OR) for CVD risk were elevated in the least active quintile of PA (OR: 2.58)
compared with the most active quintile as well as the second quintile for vigorous PA (OR: 2.91). Compared with
the most active quintile, older children in the first, second and third quintiles had OR for CVD risk score CRFs + fit
ranging from OR 2.69 to 5.40 in boys, and from OR 2.85 to 7.05 in girls.
Conclusions: PA is important to protect against clustering of CVD risk factors in young children, being more
consistent in those older than 6 years. Healthcare professionals should recommend around 60 and 85 min/day of
moderate-to-vigorous PA, including 20 min/day of vigorous PA.
Please see related commentary: http://www.biomedcentral.com/1741-7015/11/173.
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The risk for future cardiovascular disease (CVD) in appar-
ently healthy children can be assessed by a clustering of
individual risk factors in the same individual, as it describes
a status with several of these risk factors being high simul-
taneously [1]. A risk factor understands as a key parameter
that can model the risk for CVD. Obesity is one of the main
risk factors associated with increased CVD risk in children
and adolescents [2]. Specifically, conditions such as
overweight and obesity in children have, in recent years,
reached epidemic proportions and they are still rapidly
increasing, with marked effects at all socioeconomic
levels and across ethnicities [3-5]. Recently, several reviews
have highlighted the relevance of physical activity (PA)
as the main therapeutic tool for combating CVD risk in
children and adolescents [6-8]. The use of objectively-
measured PA as well as the use of clusters of metabolic
risk have been suggested as being appropriate for more
precise analysis of these relationships [6]. Several stud-
ies have shown an inverse relationship between object-
ive PA and metabolic syndrome risk factors in healthy
children and adolescents [9-16]. Most of the studies
analyzing the association between PA and CVD risk are
based on children from different parts of the European
Youth Heart Study, with children of 9 and 15 years of
age [9,10,12-14,16]. All of these studies observed an in-
verse relationship. Recently, this inverse association has
also been observed in a relatively small study (n = 223)
performed with Swedish children aged 8 to 11 years
[15]. Only one cross-sectional study has addressed these
relationships in children aged <9 years, in particular in
younger children (<6 years) [11]. Butte et al. studied a
sample of 897 Hispanic children (4 to 19 years) in the USA;
they observed no association of PA with the presence of
CVD risk, but a significant association was found with the
number of components included in the concept of meta-
bolic syndrome (from 0 to 5 components such as high waist
circumference, lower high-density lipoprotein cholesterol
(HDL-c), higher levels of hypertriglyceridemia, high blood
pressure, and fasting glucose) [11]. Finally, the group
of Andersen et al. failed to find any association at age of 6
years (n = 435), although concluded that a clustering of
CVD risk factors developed between the age of 6 and 9
years [1,17]. To the best of our knowledge, there has not
been any study analyzing the association of objectively-
measured PA in relation to clustered CVD risk factors
focusing on children aged from 2 to 9 years, with gender-
specific information, in a relatively large sample.
Since 2000, there have been several PA recommendations
with respect to duration and intensity required to ensure a
healthy lifestyle in children and adolescents (age range:
6 to 17 years) [9,18-23] and movement coordination benefits
in younger children (age range: 2 to 5 years) [24]. The
consensus recommendation has been that children andadolescents should participate in ≥60 minutes of PA of mod-
erate to vigorous intensity daily (or most days of the week)
[18-23]. Later, in 2006, Andersen et al. recommended daily
PA of 90 minutes duration based on their findings in
children aged 9 and 15 years [9]. Conversely, Wittmeier
et al. suggested 60 minutes per day instead of 90 minutes
in children aged 8 to 11 years as an attainable goal in view
of the lower percentage of those achieving higher intensity
activity in their study [18]. Finally, in 2007 a recommen-
dation of 60 minutes of PA was made for young children
(2 to 5 years) based on evidence of benefits accruing
with respect to cognitive performance and motor skills.
However, there was not enough evidence to suggest
metabolic improvement [24]. Hence, more specific rec-
ommendations on PA (levels and intensities) for health
benefits are needed, especially in relation to age groups
(including those <6 years) and/or gender.
The objectives of the present study were: (1) to evaluate
the associations between objectively-measured PA in-
tensities and clustered CVD risk factors in a large sample
of European children aged 2 to 9 years, and (2) to provide
evidence for the development of gender-specific recom-
mendations of PA for this young population.
Methods
Study population
Data used in the current analysis were derived from the
IDEFICS (‘Identification and prevention of Dietary- and
lifestyle-induced health EFfects In Children and infantS’)
study. A total of 16,224 children aged 2 to 9 years were
recruited during the baseline survey, which was conducted
between 2007 and 2008 in 8 European countries (Italy,
Estonia, Cyprus, Belgium, Sweden, Germany, Hungary,
Spain) [25]. All participants met the general IDEFICS
inclusion criteria: age group 2 to 9 years, available data
on body mass and height, and completion of the parental
questionnaire. From the total sample of 16,224 children,
a subset of 12,134 had valid data for age, body mass,
height, body mass index (BMI) and blood sample parame-
ters. As accelerometry was measured only in a subset from
every center due to availability of accelerometers, when the
objective measurement of PA was included in the analyses
the sample size was reduced. For the purposes of the
current analyses, only subjects (n = 3,019) with a complete
set of data that included total triglycerides (TG), total chol-
esterol (TC), HDL-c, glucose, insulin, systolic blood pres-
sure (SBP), sum of two skinfold thickness measurements,
exposure (PA intensities) and confounding variables were
included. No differences with respect to mean age, body
mass and Z score BMI were observed between individuals
in the subset with complete data and the rest of the sample.
The study was conducted according to the standards of the
Declaration of Helsinki. (Edinburgh 2000 revision), the
Good Clinical Practice, and the legislation about clinical
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mental regulations pertaining to the ethical use of human
volunteers were followed during this research. Approval by
the appropriate ethics committees was obtained by
each of the eight participating centers carrying out
the fieldwork (Belgium: Ethics Committee, University
Hospital, Gent; Cyprus: Cyprus National Bioethics
Committee; Estonia: Tallinn Medical Research Ethics
Committee; Germany: Ethics Committee, University of
Bremen; Hungary: Egészségügyi Tudományos Tanács, Pécs;
Italy: Comitato Etico, ASL Avellino; Spain: Comité Ético
de Investigación, Clínica de Aragón (CEICA); Sweden:
Regional Ethics Review Board, University of Gothenburg).
Written informed consent was obtained from the parents
(or guardian) of each child participating in the study.
Measurements
For quality management, all measurements followed de-
tailed standard operating procedures that were laid down in
the general survey manual and finalized after the pretest of
all survey modules [26]. Field personnel from each study
center participated in the central training and organized
local training sessions thereafter. The coordinating center
conducted site visits to each study location during both
field surveys to check adherence of field [25].
Socioeconomic status (SES)
SES was estimated using the International Standard
Classification of Education. A score was calculated from
the highest education and qualification levels of both par-
ents. Five groups were defined using a scale from 0 to 6:
level 1 (0 and 1), level 2 (2), level 3 (3), level 4 (4), and level
5 (5 and 6); the lower the score, the lower SES.
Physical examinations
Body mass was measured in light clothing to the nearest
0.1 kg with an electronic scale (TANITA BC 420 SMA,
Tokyo, Japan). Height was measured without shoes to
the nearest 0.1 cm using a stadiometer (Seca 225; Seca,
Hamburg, Germany). Skinfold thicknesses were measured
with a Holtain caliper (Holtain Ltd., Croswell, UK)
at the triceps and subscapular sites. Blood pressure
was measured with an electronic sphygmomanometer
(Welch Allyn 4200B-E2; Welch Allyn, Aston Abbotts, UK)
[27] preferably in the right arm with the child seated and
in a calm environment. Two measurements were taken at
2-minute intervals and, if they differed by >5%, a third
measurement was taken. The mean of the two (or three)
measurements was used in all statistical analyses.
Physical activity
The uniaxial Actigraph accelerometer (Actigraph
MTI, model GT1M; Manufacturing Technology Inc.,
Fort Walton Beach, FL, USA) and the ActiTrainer(http://www.actitrainer.com) were used to measure PA.
The ActiTrainer technology is based on the ActiGraph
accelerometer with additional functions (heart rate). The
rationale to use the ActiGraph in younger and ActiTrainer
in older children was to record, when possible, the heart
rate. However, in the current study only data from acceler-
ometers were used and crossvalidation was not necessary
as both accelerometers are essentially the same model of
ActiGraph. Prior to data collection, parents were instructed
in the correct positioning of the accelerometer; that is,
to attach the accelerometer to the right hip of the child
during their waking day by means of an elastic belt ad-
justed to ensure close contact with the body. The ac-
celerometer needed to be worn all day over 4 to 5 days,
except during water-based activities and during sleep.
Recordings were for at least 6 h/day for at least 3 days
(2 weekdays and 1 day of the weekend or holiday) in
accord with the results of the reliability analysis indi-
cating a minimum duration of 6 h per day of monitor-
ing to achieve 80% reliability [28]. The sampling interval
(epoch) was set at 15 s. Non-wear time was excluded
from the data by means of an automated method that
uses an algorithm developed using R (version R 2.9.0.; R
Foundation for Statistical Computing, Vienna, Austria;
http://www.R-project.org). Thus, periods of 20 minutes
or more consecutive zero counts were replaced by miss-
ing data code before further analysis [28]. A measure of
average total volume of activity (hereafter called total PA)
was expressed as the sum of recorded counts divided
by total daily registered time expressed in minutes
(counts/minute; cpm). The cut-offs to define the PA in-
tensity categories were derived from previously-validated
cut-offs [29], with time spent in light PA (minutes) defined
as the sum of time-per-day in which counts per epoch
were 26 to 573 cpm. The time engaged in moderate PA
was calculated based upon a cut-off of 574 to 1,002
cpm per epoch. The time engaged in vigorous PA was
calculated based upon a cut-off of ≥1,003 cpm per
epoch. In addition, the time spent at the ‘effective’ in-
tensity level was calculated as the sum of time spent in
moderate + vigorous PA (MVPA).
Cardiorespiratory fitness
Fitness was measured by the progressive 20-m shuttle
run test [30]. This test required subjects to run back
and forth between two lines set 20 m apart at a pace
determined by audio signals. The initial speed was set
at 8.5 km/h increasing by 0.5 km/h every minute (1 minute
equals 1 stage). The test was completed when the
child failed to reach the end lines in time with the
audio signals on two consecutive occasions. The final
score was computed as the number of stages com-
pleted (precision of 0.5 stages). Stages completed were
used to estimate the VO2max [30].
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A detailed description of the blood sampling procedures
has been published elsewhere [31]. Briefly, blood samples
were obtained after an overnight fast and previous confirm-
ation by questionnaire of achievement this criterion. Blood
glucose, TC, HDL-c and TG were assessed on site at each
study center by point-of-care analysis using a Cholestech
LDX analyzer (Cholestech, Hayward, CA, USA) [32].
Serum insulin concentrations were determined by lu-
minescence immunoassay in a central laboratory using an
AUTO-GA Immulite 2000, Siemens, Eschborn, Germany.
To derive a measure of insulin resistance we used the
homeostasis model assessment (HOMA-IR) [33] using
fasting glucose and plasma insulin according to the follow-
ing formula: HOMA-IR = [fasting insulin (pmol/l)/6.945] ×
[fasting glucose (mmol/l)/22.5].
Cardiovascular risk score
According to Andersen et al. [9] a continuous score
clustering CVD risk factors (CRFs) was computed using the
following variables: SBP, TG, TC/HDL-c ratio, HOMA-IR,
and sum of two skinfolds (score CRFs). Since the 20-m
shuttle run test was only performed in children >6 years
of age, a second CVD risk score was obtained for older
children containing the score CRFs + the cardiorespira-
tory fitness variable using the total number of stages
(termed score CRFs + fit). Z scores were calculated for
each risk factor variable by age and gender, followed by
a summing of individual Z scores to create the two clus-
tered risk scores. Cardiorespiratory fitness Z score was
multiplied by -1 to indicate higher metabolic risk with
increasing value. The lower the CVD risk the better the
overall CVD risk factor profile.
Statistical analysis
Predictive Analytics SoftWare (PASW, version 18; SPSS
Inc., Chicago, IL, USA) was used to perform the analyses.
Statistical significance was set at P <0.05. The data are
presented as mean ± standard deviation (SD) unless
otherwise stated. Mean and SD for CVD risk were cal-
culated for age and gender groupings of the children
who had a complete set of measurements. Age groups
were recorded as younger children (between 2 to 6 years)
and older children (between 6 to 9 years). The distribu-
tions of PA were observed to be skewed and so to
achieve normality of distributions, moderate PA, vigor-
ous PA, and MVPA were transformed to the natural
logarithm values. Individuals >1 SD away from the
mean in the clustered risk scores were defined as being
‘at risk’. For descriptive variables, the Student’s t test
was used to test the differences between genders. To
examine the association between PA intensities and
CVD risk scores, partial correlation analyses adjusted
for country were conducted in both age groups.Age and gender-specific quintiles were created for each
PA intensity. One-way analysis of covariance (ANCOVA)
was used to test the differences in CVD risk scores
(dependent variables) among quintiles of PA (fixed factor)
segregated by age and gender and adjusted for country
(dummy variable) and SES.
Logistic regression models were used to calculate
the odds ratios (OR) for having clustered risk score
(dichotomous variable; Z score above 1 SD) across quintiles
of different PA intensities (quintile 5 as reference) segre-
gated by age and gender. Country (dummy variable) and
SES were included as covariates. Moreover, descriptive
analyses were performed to stand out the mean, SD and
range of time corresponding at each quintile among the
different PA intensities segregated by age and gender.
Finally, the mean, SD and range at the highest quintile
(Q5) of PA was selected as potential recommendation.
Results
Descriptive characteristic of the study sample
Table 1 summarizes the descriptive characteristics of the
study sample. In younger children, girls had significantly
higher sum of two skinfolds, insulin and HOMA-IR
values than boys (all P <0.001), while the boys had higher
weight, height, glucose, HDL-c and all PA intensities
(except vigorous PA) than girls (all P <0.05). Age, BMI,
SBP, diastolic blood pressure (DBP), TC, TG, vigorous PA
and CVD risk score CRF mean values were similar between
genders. In older children, girls had significantly higher
sum of two skinfolds, insulin, HOMA-IR, TC and TG
values than boys (all P <0.01), while boys had greater
height, SBP, glucose, HDL-c, moderate, vigorous, MVPA
and total PA as well as cardiorespiratory fitness than their
female counterparts (all P <0.05). The means of age, weight,
BMI and CVD risk scores (CRFs and CRFs + fit) were simi-
lar in both genders. When the Bonferroni correction factor
for multiple tests was applied, only those with P <0.0025
remained significant.
Correlations
Partial correlations between PA intensities and CVD risk
scores (CRFs and CRFs + fit) in both age groups were
investigated following adjustment for country. In young
children, only vigorous PA was inversely correlated with
the CVD risk score CRFs (r: -0.086; P <0.01; n = 994). In
older children, moderate PA, vigorous PA, MVPA and total
PA intensities were inversely correlated with both CVD risk
scores (score CRFs ranged from -0.089 to -0.166, all
P <0.01, n = 2,025; score CRFs + fit ranged from -0.111
to -0.251, all P <0.001, n = 835).
Differences in mean Z score by quintiles of PA
Vigorous PA intensity was the only PA variable that was
associated with CVD risk score in younger children. In
Table 1 Descriptive characteristics of the study participants
Characteristic All Boys Girls P value
Group 2 to 6 years n = 994 n = 524 n = 470
Age, years 4.4 ± 0.8 4.5 ± 0.8 4.4 ± 0.8 0.226
Body mass, kg 18.3 ± 3.5 18.5 ± 3.5 18.0 ± 3.4 0.011
Height, cm 107.2 ± 7.4 107.8 ± 7.4 106.6 ± 7.5 0.011
BMI, kg/m2a 15.8 ± 1.7 15.9 ± 1.6 15.7 ± 1.8 0.170
Sum of two skinfolds, mma 16.5 ± 5.0 15.3 ±54.3 17.7 ± 5.3 <0.001b
DBP, mmHg 62.1 ± 6.2 62.0 ± 6.1 62.2 ± 6.3 0.617
SBP, mmHg 97.4 ± 8.4 97.7 ± 8.5 97.1 ± 8.2 0.238
Glucose, mmol/l 4.51 ± 0.51 4.55 ± 0.54 4.46 ± 0.48 0.010
Insulin, pmol/la 22.64 ± 18.47 21.39 ± 17.36 24.10 ± 19.52 0.011
HOMA-IRa 0.68 ± 0.62 0.65 ± 0.57 0.72 ± 0.66 0.011
Cholesterol, mmol/l 4.02 ± 0.73 3.99 ± 0.72 4.06 ± 0.74 0.127
HDL-c, mmol/l 1.23 ± 0.34 1.29 ± 0.33 1.19 ± 0.35 0.001b
Triglycerides, mmol/l 0.46 ± 0.25 0.45 ± 0.23 0.48 ± 0.28 0.188
Light PA, min/daya 395 ± 65 400 ± 65 390 ± 66 0.019
Moderate PA, min/daya 31 ± 16 34 ± 17 27 ± 14 <0.001b
Vigorous PA, min/daya 5 ± 5 6 ± 6 5 ± 5 0.281
MVPA, min/daya 36 ± 20 39 ± 21 32 ± 17 <0.001b
Total PA, cpm 598 ± 174 627 ± 179 565 ± 162 <0.001b
CVD risk score CRFs 0.02 ± 2.74 0.01 ± 2.70 0.03 ± 2.77 0.879
Group 6 to 9 years n = 2,025 n = 1,038 n = 987
Age, years 7.6 ± 0.8 7.6 ± 0.8 7.6 ± 0.8 0.926
Body mass, kg 27.7 ± 6.7 28.0 ± 6.9 27.5 ± 6.3 0.088
Height, cm 127.5 ± 7.3 128.2 ± 7.4 126.9 ± 7.3 <0.001b
BMI, kg/m2a 16.9 ± 2.9 16.9 ± 3.0 16.9 ± 2.8 0.618
Sum of two skinfolds, mma 19.8 ± 9.5 18.3 ± 9.2 21.4 ± 9.2 0.070
DBP, mmHg 64.2 ± 6.5 64.0 ± 6.7 64.5 ± 6.3 0.018
SBP, mmHg 103.2 ± 8.7 103.7 ± 8.7 102.8 ± 8.6 0.070
Glucose: mmol/l 4.81 ± 0.52 4.88 ± 0.52 4.75 ± 0.49 <0.001b
Insulin, pmol/la 35.84 ± 24.65 33.41 ± 22.43 38.34 ± 24.93 <0.001b
HOMA-IRa 1.13 ± 0.83 1.07 ± 0.77 1.20 ± 0.84 <0.001b
Cholesterol, mmol/l 4.19 ± 0.83 4.11 ± 0.77 4.28 ± 0.84 <0.001b
HDL-c, mmol/l 1.40 ± 0.38 1.42 ± 0.39 1.38 ± 0.37 0.016
Triglycerides, mmol/l 0.47 ± 0.26 0.45 ± 0.24 0.49 ± 0.29 <0.001b
Light PA, min/daya 364 ± 64 364 ± 63 364 ± 17 0.940
Moderate PA, min/daya 35 ± 17 41 ± 19 30 ± 12 <0.001b
Vigorous PA, min/daya 8 ± 6 8 ± 6 7 ± 8 0.001b
MVPA, min/daya 43 ± 22 49 ± 23 37 ± 18 <0.001b
Total PA, cpm 581 ± 169 609 ± 175 553 ± 157 <0.001b
Cardiorespiratory fitness, ml/kg/minc 41.7 ± 14.5 42.2 ± 14.3 41.3 ± 13.8 0.01
Stages (total number) 1.9 ± 1.3 2.1 ± 1.5 1.7 ± 1.1 <0.001b
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Table 1 Descriptive characteristics of the study participants (Continued)
CVD risk score CRFs 0.13 ± 3.11 0.09 ± 3.03 0.18 ± 3.19 0.501
CVD risk score CRFs + fitc −0.28 ± 3.26 −0.26 ± 3.016 −0.31 ± 3.36 0.775
CVD risk score CRFs includes SBP, HOMA-IR, ratio cholesterol/HDL-c, triglycerides and sum of two skinfolds; CVD risk score CRFs + fit added
cardiorespiratory fitness.
aNon-transformed data are presented in this table but analyses were performed on log-transformed data.
bSignificant differences after to apply the Bonferroni correction factor for multiple tests.
cSample size including cardiorespiratory fitness was 835 participants (414 boys).
BMI body mass index, CRF CVD risk factor, CVD cardiovascular disease, DBP diastolic blood pressure, HDL high-density lipoprotein, HOMA-IR homeostasis model
assessment, MVPA moderate + vigorous PA, PA physical activity, SBP systolic blood pressure.
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risk scores in older children and, consequently, was used
in subsequent analyses. Total PA was also used as an
overall activity indicator. Figure 1 (A to D) depicts mean
Z score in each quintile of PA segregated by age and
gender groups. In younger children, non-significant
differences in CVD risk score CRFs through quintiles
of vigorous (Figure 1A-B) and total PA (Figure 1C-D)
were observed. In older children, significantly lower
values of CVD risk score CRFs + fit through quintiles
of vigorous PA (Figure 1A-B) and total PA (Figure 1C-D)
were observed in both genders (all P <0.01). Additional
analyses using score A instead of score B showed similar re-
sults. Additional sensitivity analyses using tertiles instead of
quintiles or the PA cut-offs of van Cauwenberghe et al. [34]
were made, and the results did not change substantially.
Likelihood for metabolic risk
The risks of having CVD risk score CRFs (dichotomous
Z score >1 SD) for PA intensities in children from both age
groups are summarized in Table 2. In young boys, the ORs,
compared with the most active quintile, were raised in the
least active quintile of total PA 2.58 (95% CI 1.07 to 6.18)
and in the second quintile for vigorous PA (OR: 2.91; 95%
CI 1.25 to 6.82). In older children, the risk of having CVD
risk score CRFs decreased with increased activity for all PA
intensities. OR for the least active quintiles compared to
the most active quintiles of the different PA intensities
ranged from 2.69 to 3.82 and 2.32 to 2.95 in boys and
girls, respectively (Table 2). When the CVD risk score was
calculated using BMI instead of the sum of two skinfold
thickness measurements, the results did not change sub-
stantially. When sensitivity analyses using tertiles instead
of quintiles or other PA cut-offs [34] were used, the results
did not change substantially.
Since cardiorespiratory fitness data were only available
for older children, the logistic regression analyses were
repeated for the CVD score CRFs + fit including the recip-
rocal of the cardiorespiratory fitness scores. The results
for both genders are summarized in Table 3. Likelihood
ratios for score CRFs + fit were higher than for score
CRFs. Children in the first, second and third quintiles had
OR for CVD risk score ranging from 2.69 to 5.40 in boys
and from 2.85 to 7.05 in girls, relative to the most activequintile. Sensitivity analyses did not change the results
substantially. Table 4 summarizes the time-per-day spent
at the different PA intensities in the five quintiles of PA,
and the cpm of total PA.
Discussion
The main findings of the study were the inverse associations
between PA and clustered CVD risk factor scores. The risk
was raised in the first to third quintiles of PA for older chil-
dren compared to the most active quintile, while in younger
children some inverse association were found only for boys,
but not sufficiently consistent. The time spent at MVPA in
the fifth quintile was a mean of 85 minutes and 66 minutes
in older children (boys and girls, respectively); therefore, the
current recommendation for PA of at least 60 min/day of at
least moderate intensity in order to avoid the negative con-
sequences of clustering of risk factors could be appropriate
for girls but might be a slight underestimate for boys.
Comparison with other studies
Our findings concur with others that had observed inverse
associations between PA and CVD risk factors [9-16].
However, most of these studies had been conducted in
children at the ages of 9 and 15 years. Our study observed
this inverse relationship between objectively-measured PA
and CVD risk score in children aged 2 to 9 years who con-
stitute a less well investigated age range, establishing that
there is only consistent evidence for children aged 6 to 9
years. In addition, our results provided more relevant
gender-specific data on the strength of association and the
PA intensities. Moreover, Butte et al. performed the only
study with children aged of 4 to 19 years, but failed to
show a clear association between PA and CVD risk factors
[11]. In a first approach the correlations were significant,
although small variances were seen, which could be par-
tially due to the overall low PA levels found in this sample.
Despite that, in the present study an inverse relationship
between PA and CVD risk score was found consistently in
older boys and girls (6 to 9 years). The weaker associations
observed exclusively in younger boys may be due to these
CVD risk factors not being manifest as yet in this age
group of particularly young children (2 to 6 years); this is
in accord with other authors who failed to found any asso-
ciation in younger children (6 years old) [1,17]. Moreover,
Figure 1 Cardiovascular disease (CVD) risk score and physical activity (PA) intensities in children aged 2 to 9 years. (A) Vigorous PA in
younger children (2 to 6 years); (B) vigorous PA in older children (6 to 9 years); (C) total PA in younger children (2 to 6 years); (D) total PA in
older children (6 to 9 years). Vertical bars show mean ± standard error. *P <0.01 compared to lower quintile. Q5, reference as highest PA levels.
Jiménez-Pavón et al. BMC Medicine 2013, 11:172 Page 7 of 11
http://www.biomedcentral.com/1741-7015/11/172
Table 2 Odds ratios for cardiovascular disease risk score CRFs by quintiles of PA
Group Quintile Total PA Moderate PA Vigorous PA MVPA
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Boys (2 to 6 years)
n = 524 Q1 2.58 1.07 to 6.18 1.26 0.55 to 2.88 1.23 0.46 to 3.26 1.39 0.56 to 3.45
Q2 1.59 0.65 to 3.91 1.27 0.57 to 2.83 2.91 1.25 to 6.82 2.21 0.95 to 5.15
Q3 1.31 0.55 to 3.16 1.17 0.51 to 2.66 1.98 0.79 to 4.93 1.98 0.85 to 4.58
Q4 2.21 0.98 to 4.98 1.23 0.56 to 2.69 2.14 0.89 to 5.15 1.62 0.68 to 3.85
Q5 (reference) 1 1 1 1
Girls (2 to 6 years)
n = 470 Q1 1.03 0.43 to 2.47 0.77 0.32 to 1.85 2.54 0.88 to 7.29 1.23 0.48 to 3.17
Q2 0.76 0.32 to 1.85 0.80 0.33 to 1.93 2.71 0.96 to 7.70 1.18 0.45 to 3.08
Q3 0.81 0.34 to 1.90 0.69 0.29 to 1.67 1.68 0.55 to 5.15 1.26 0.50 to 3.13
Q4 0.72 0.31 to 1.63 0.67 0.28 to 1.62 2.29 0.82 to 6.37 1.20 0.48 to 2.98
Q5 (reference) 1 1 1 1
Boys (6 to 9 years)
n = 1,038 Q1 3.26 1.74 to 6.10 3.58 1.95 to 6.55 3.82 2.05 to 7.16 3.77 2.04 to 6.96
Q2 1.70 0.89 to 3.25 1.38 0.75 to 2.53 2.70 1.45 to 5.14 1.98 1.04 to 3.77
Q3 2.00 1.06 to 3.79 1.29 0.70 to 2.38 2.01 1.04 to 3.89 1.32 0.67 to 2.59
Q4 1.10 0.55 to 2.20 0.50 0.24 to 1.06 1.78 0.88 to 3.59 1.23 0.61 to 2.46
Q5 (reference) 1 1 1 1
Girls (6 to 9 years)
n = 987 Q1 1.72 0.90 to 3.30 2.54 1.33 to 4.86 2.49 1.37 to 4.52 2.95 1.55 to 5.61
Q2 2.47 1.34 to 4.56 2.78 1.46 to 5.24 1.90 1.03 to 3.50 2.70 1.43 to 5.10
Q3 1.87 1.01 to 3.45 2.44 1.29 to 4.62 1.78 0.94 to 3.39 2.11 1.11 to 4.12
Q4 1.31 0.69 to 2.51 1.13 0.56 to 2.28 1.18 0.59 to 2.34 1.27 0.64 to 2.52
Q5 (reference) 1 1 1 1
CVD risk score A includes SBP, HOMA-IR, ratio cholesterol/HDL-c, triglycerides and sum of two skinfold measurements. Significant associations are highlighted in bold.
CRF CVD risk factor, CVD cardiovascular disease, HDL high-density lipoprotein, HOMA-IR homeostasis model assessment, MVPA moderate + vigorous PA, PA
physical activity, Q quintile, Q5 reference as highest PA levels, SBP systolic blood pressure.
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impossibility to use the score with cardiorespiratory fitness,
could hamper the sensitivity in detecting associations [35].
However, more studies should look at this age range in
order to corroborate that assumption. Non-concordance
between studies could be due to methodological differences
such as sample size (lower in others vs current study), ethnic
origin, age range, and stratification of the data for analysis.
The present study focused on children aged 2 to 9
years. This is a younger age group than the age groups
included in those studies on which previous recommen-
dations had been based (6 to 17 years) [9,18-23]. Since
the consensus is that PA requirements should be age
specific [7] our data analyses were performed in two age
groups: 2 to 6 and 6 to 9 years of age. This enables, for the
first time, separate recommendations to be formulated for
children <6 years of age, and for those who are older.
Nevertheless, the lack of consistency in the younger group
make it necessary to be cautious when interpreting thelevels of PA in younger children, as it should not be used
for recommendation but only for description. Our study
observed that, in girls from the older age group, the
current recommendation [23] of PA of at least 60 min/day
of at least moderate intensity could be enough to prevent
the negative consequences of CVD risk factor scores.
However, in boys from the same age group, 85 minutes
(rather than 60 minutes) could be a more appropriate
threshold to ensure a lower CVD risk factor score and this
value is close to the 90 minutes daily PA suggested by
Andersen et al. [9]. Further, an important finding in our
study is that the mean time spent on vigorous PA in older
children should be around 20 min/day. Our findings re-
garding time spent at vigorous PA in order to pre-empt
potential CVD risk are in agreement with other studies,
which observed that a similar amount of vigorous PA can
discriminate between normal weight and overweight [36]
while being associated with better bone mineral content
[37]. To the best of our knowledge, ours is the first study
Table 4 Time per day spent at the different PA intensities in the five quintiles of PA
Quintiles by group Total PA Moderate PA Vigorous PA MVPA
Counts/min SD Range Min/day SD Range Min/day SD Range Min/day SD Range
Boys (2 to 6 years)
Q1 389.6 59.7 187.2 to 470.9 13.3 4.1 1.3 to 18.7 0.9 0.4 0.2 to 1.5 14.9 4.6 1.3 to 21.3
Q2 525.2 28.2 470.9 to 572.0 22.9 2.2 18.8 to 26.3 2.3 0.4 1.7 to 3.0 25.9 2.4 21.7 to 29.8
Q3 616.4 24.9 572.4 to 659.6 31.0 2.7 26.5 to 35.6 3.9 0.4 3.3 to 4.7 35.3 2.9 30.3 to 39.8
Q4 708.8 31.6 659.8 to 765.8 41.2 3.8 35.7 to 47.7 6.2 1.1 4.8 to 8.5 48.1 4.7 40.3 to 57.2
Q5 (reference) 893.7 97.5 769.0 to 1,239.8 61.1 11.1 48.0 to 115.7 14.7 6.3 8.7 to 37.7 73.2 13.2 57.3 to 141.0
Girls (2 to 6 years)
Q1 357.3 58.2 173.9 to 428.2 10.1 3.0 14.8 to 21.5 0.9 0.4 0.2 to 1.4 11.3 3.6 3.3 to 16.7
Q2 473.2 24 432.8 to 516.2 18.2 2.1 22.0 to 29.7 2.2 0.4 1.6 to 2.8 21.5 2.5 17.0 to 25.3
Q3 548.5 19.7 516.7 to 582.4 25.7 2.1 29.8 to 38.0 3.9 0.6 3.0 to 4.8 30.0 2.7 25.8 to 34.3
Q4 637.4 32.4 584.1 to 693.4 33.7 2.4 38.3 to 77.7 6.1 0.8 5.0 to 7.8 39.9 3.0 35.0 to 45.3
Q5 (reference) 806.7 103 694.8 to 1,210.6 47.9 9.2 24.7 to 34.3 12.2 6.0 8.0 to 58.3 57.8 11.7 45.3 to 107.0
Boys (6 to 9 years)
Q1 383.5 60.6 165.4 to 461.4 17.5 5.2 3.0 to 24.3 1.6 0.7 0.3 to 2.8 20.3 6.2 3.0 to 28.5
Q2 507.6 24.7 461.4 to 548.2 29.7 2.8 24.7 to 34.3 3.8 0.6 3.0 to 4.9 34.8 3.4 28.7 to 40.3
Q3 594.4 24.3 548.6 to 635.8 38.2 2.4 34.3 to 42.6 6.1 0.8 5.0 to 7.6 45.4 3.1 40.6 to 50.8
Q4 690.3 34.4 635.9 to 752.7 48.2 3.5 42.7 to 54.5 9.9 1.3 7.8 to 12.3 57.4 4.5 51.0 to 65.8
Q5 (reference) 871.1 99.9 753.2 to 1,258.7 69.3 12.3 54.8 to 115.0 18.3 5.8 12.3 to 42.0 84.6 15.4 66.3 to 137.5
Girls (6 to 9 years)
Q1 354.3 52.6 123.1 to 414.0 12.6 3.7 1.3 to 17.8 1.5 0.6 0.3 to 2.4 15.0 4.6 1.3 to 21.8
Q2 459.1 24.5 414.7 to 499.5 21.3 2.0 18.3 to 24.6 3.3 0.5 2.6 to 4.2 26.0 2.6 21.8 to 30.0
Q3 538.6 21.9 499.8 to 575.7 28.2 2.1 24.8 to 31.8 5.3 0.7 4.3 to 6.5 34.3 2.4 30.3 to 38.7
Q4 621.0 28.9 575.7 to 677.9 36.2 2.8 32.0 to 41.3 8.5 1.1 6.7 to 10.7 45.0 3.3 39.2 to 51.3
Q5 (reference) 789.9 97.7 680.7 to 1,198.9 52.5 9.4 41.7 to 103.5 17.3 5.9 11.3 to 46.3 66.4 13.1 53.1 to 131.5
PA physical activity, MVPA moderate + vigorous PA, Q quintile, Q5 reference as highest PA levels.
Table 3 Odds ratios for cardiovascular disease risk score CRFs + fit by quintiles of PA
Group Quintile Total PA Moderate PA Vigorous PA MVPA
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Boys (6 to 9 years)
n = 414 Q1 3.36 1.17 to 9.64 5.40 2.05 to 14.20 2.69 1.06 to 6.80 4.36 1.62 to 11.71
Q2 1.61 0.61 to 4.21 2.05 0.76 to 5.58 1.65 0.66 to 4.16 2.38 0.91 to 6.23
Q3 1.91 0.79 to 4.61 2.00 0.75 to 5.31 1.15 0.44 to 2.99 2.06 0.78 to 5.48
Q4 0.95 0.36 to 2.48 1.16 0.42 to 3.20 0.73 0.26 to 2.04 1.29 0.47 to 3.56
Q5 (reference) 1 1 1 1
Girls (6 to 9 years)
n = 421 Q1 2.20 0.68 to 7.16 3.70 1.21 to 11.29 5.88 2.20 to 15.76 5.95 1.86 to 19.05
Q2 4.07 1.66 to 9.98 4.46 1.69 to 11.77 2.85 1.02 to 7.96 7.05 2.47 to 20.15
Q3 2.94 1.29 to 6.70 5.34 2.12 to 13.42 1.87 0.64 to 5.51 5.23 1.81 to 15.13
Q4 1.59 0.65 to 3.93 1.88 0.66 to 5.38 1.84 0.63 to 5.36 3.46 1.17 to 10.26
Q5 (reference) 1 1 1 1
CVD risk score B includes SBP, HOMA-IR, ratio cholesterol/HDL-c, triglycerides, sum of two skinfolds and cardiorespiratory fitness. Significant associations are
highlighted in bold.
CRF CVD risk factor, CVD cardiovascular disease, HDL high-density lipoprotein, HOMA-IR homeostasis model assessment, MVPA moderate + vigorous PA, PA
physical activity, Q quintile, Q5 reference as highest PA levels, SBP systolic blood pressure.
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measured PA and clustered CVD risk factors in a large
sample of children from 2 to 9 years, as well as provid-
ing gender-specific recommendation for children aged
6 to 9 years.
Strengths and limitations
The strengths of the present study are the availability of
standardized measures of objective PA, insulin resistance
and other CVD risk factors, as well as cardiorespiratory
fitness. Further, having a well balanced gender distribution
within a large heterogeneous sample of young children
from eight European countries provides an excellent oppor-
tunity to derive gender-specific data. To date, studies re-
garding the association between PA and CVD risk factors
(as well as the current guidelines for PA) have been focused
mainly on older children. Our study, instead, covers ages
from 2 to 9 years. These aspects are of interest for public
health since they provide new insights into PA needs and
recommendations for younger children that may used by
physicians and other healthcare workers.
The present study has several limitations, however.
The cross-sectional nature of the study precludes deter-
mining any causality in the findings. The overall healthy
sample, with only 15% of children above 1 SD of the CVD
score, could limit the interpretation of the present results,
particularly in a less healthy population. Only interven-
tional studies with exercise could establish whether or not
these specific recommendations are effective in reducing
cardiovascular risk, and our findings have not established
the efficacy of these recommendations. More randomized
controlled trials and prospective studies are needed to
focus on improving CVD risk factor status through in-
creasing the volume and intensity of PA and differenti-
ating by age range.
Conclusions
PA is important to prevent a clustering of risk factors in
young children aged 6 to 9 years. In clinical settings,
practitioners should recommend that, in girls, the
current guidelines of at least 60 min/day of PA of at least
moderate intensity could be enough, but around 20 of
these minutes should be of vigorous intensity. However
in boys, 85 min/day MVPA including around 20 minutes
vigorous PA could be necessary to prevent the negative
consequences ascribed to clustering of risk factors. In
younger children aged 2 to 6 years it seems that this role
of PA is less consistent than in older children based on
the low numbers of significant associations, although in-
dications of some influence of PA as a preventive tool
were observed in such young children. The assessment
of how changes in PA volume and intensity can causally
affect clustering of CVD risk factors in young children
remains to be properly explored. Future interventionsare needed to identify how much increase in PA inten-
sity and volume would be required to improve CVD risk
factor status.
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